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Hansen, Pernille B., Seiji Hashimoto, Josie Briggs,
and Jurgen Schnermann. Attenuated renovascular con-
strictor responses to angiotensin II in adenosine 1 receptor
knockout mice. Am J Physiol Regul Integr Comp Physiol 285:
R44–R49, 2003; 10.1152/ajpregu.00739.2002.—In the present
experiments we examined the renovascular constrictor ef-
fects of ANG II in the chronic and complete absence of A1
adenosine receptors (A1AR) using mice with targeted dele-
tion of the A1AR gene. Glomerular filtration rate (GFR) was
not different between A1AR / and A1AR / mice under
control conditions (450.5  60 vs. 475.2  62.5 l/min) but
fell significantly less in A1AR / mice during infusion of
ANG II at 1.5 ng/min (A1AR /: 242  32.5 l/min, A1AR
/: 371  42 l/min; P  0.03). Bolus injection of 1, 10, and
100 ng of ANG II reduced renal blood flow and increased
renal vascular resistance significantly more in A1AR /
than in A1AR / mice. Perfused afferent arterioles isolated
from A1AR / mice constricted in response to bath ANG II
with an EC50 of 1.5 0.4 1010 mol/l, whereas a right shift
in the dose-response relationship with an EC50 of 7.3 1.2
1010 mol/l (P  0.05) was obtained in arterioles from A1AR
/mice (P 0.05). The expression of AT1A receptor mRNA
was not different in kidney RNA from A1AR / or A1AR
/ mice. We conclude that chronic A1AR deficiency dimin-
ishes the effectiveness of ANG II to constrict renal resistance
vessels and to reduce GFR.
renal blood flow; ultrasonic flowmeter; renal vascular resis-
tance; glomerular filtration rate; perfused arterioles
PHENOMENOLOGICAL AND MECHANISTIC aspects of the ac-
tions of ANG II and adenosine in the renal vascular
bed have been explored in numerous studies. It has
been a consistent conclusion from these studies that
both agents cause an increase in renal vascular re-
sistance by eliciting vasoconstriction at multiple
sites along the renal vasculature. The renal vasocon-
strictor response of ANG II is initiated by activation
of AT1 receptors while adenosine causes vasocon-
striction through the A1 adenosine receptor (A1AR).
Several studies suggest that the degree of activation
of AT1 or A1A receptors determines the magnitude of
the constrictor effects to acute changes in the con-
centration of the other agonist. The majority of stud-
ies exploring such an interaction between adenosine
and ANG II have investigated the modifying role of
variations of ANG II on the constrictor action of
adenosine. The general approach in these studies
has been to modulate the renin-angiotensin system,
by changing NaCl intake, by utilizing mice with a
deletion of the AT1a receptor, or by acutely inhibit-
ing ANG II formation or action with angiotensin-
converting enzyme or receptor blockers. The conclu-
sion from these studies was that a reduction in AT1
activation by reducing ANG II levels or by blocking
AT1 receptors reduced the renal vasoconstrictor ef-
fect of adenosine (14, 17). The same effect was seen
when plasma renin and presumably ANG II levels
were changed by alterations in dietary Na intake,
suggesting that both acute and chronic reductions in
AT1 receptor occupation interfered with A1AR-de-
pendent vasoconstriction (11).
The converse relationship, i.e., a dependence of
ANG II vasoconstriction on simultaneous activation
of A1AR, is somewhat more controversial. For exam-
ple, in the split hydronephrotic kidney, acute block-
ade of A1AR with the A1AR antagonist 8-cyclopen-
tyl-1,3-dipropylxanthine (DPCPX) had no effect on
the constrictor effect of ANG II (4). On the other
hand, DPCPX caused an 50% reduction in the
constrictor response to ANG II in isolated and per-
fused afferent arterioles from rabbit kidneys (17).
The availability of mice with a targeted deletion of
A1AR permits the study of renal vascular responses
to ANG II during chronic and complete A1AR defi-
ciency (15). Accordingly, the present experiments
were performed to determine whether the response
of renal vascular resistance to ANG II can be shown
to be altered in A1AR knockout compared with wild-
type mice. These experiments were done as a first
step to further attempts of understanding the nature
of the interaction between ANG II and adenosine.
Our experiments show that both the vasoconstriction
and the fall in glomerular filtration rate (GFR) in
response to an acute change in angiotensin plasma
concentration are significantly blunted in the ab-
sence of functional A1AR and that this reflects at
least in part a reduced responsiveness of afferent
arterioles.
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GFR and renal blood flow experiments. Studies were per-
formed in female mice of the A1AR strain generated in this
laboratory (15). A1AR / and their littermate A1AR /
controls are maintained in a mixed J129/C57BL6 back-
ground. Genotyping was done on tail DNA using PCR as
described previously (15). Mice were in a weight range be-
tween 17 and 33 g and were kept on standard rodent chow
and tap water. Animals were anesthetized with 100 mg/kg
thiobutabarbital intraperitoneally (Inactin) and 100 mg/kg
ketamine intramuscularly. Body temperature was main-
tained at 38°C by placing the animals on an operating table
with a servocontrolled heating plate. The trachea was can-
nulated, and a stream of 100% oxygen was blown toward the
tracheal tube throughout the experiment. The femoral artery
was cannulated with hand-drawn polyethylene tubing for
continuous measurement of arterial blood pressure and blood
withdrawal. The jugular vein was cannulated for an intrave-
nous maintenance infusion of 2.25 g/dl bovine serum albumin
(BSA) in saline at a rate of 0.5 ml/h. A catheter was placed in
the bladder for urine collections.
To determine GFR, mice were infused with [125I]iothalamate
(Glofil, Questcor Pharmaceutical, Hayward, CA) at 5 Ci/h.
After 30–45 min of equilibration, three 10-min urine collection
periods were made bracketed by two blood collections of 4 l
each collected in heparinized 5-l microcaps (Drummond). An
ANG II infusion was then started at a rate of 1.5 ng/min (ANG
II concentration 1 ng/l) with a flow of 1.5 l/min without
interrupting the iothalamate infusion. Three additional 10-min
urine collections and a terminal blood collection were made.
[125I]iothalamate radioactivity was measured in duplicate
0.5-l aliquots of plasma and urine in a gamma counter.
Measurements of renal blood flow (RBF) were performed
in a separate group of A1AR / and A1AR / mice. The
left renal artery was approached from a flank incision and
carefully dissected free to permit placement of a 0.5 mm
V-type ultrasonic flow probe (Transonic Systems, Ithaca,
NY). The probe was held in place with a micromanipulator.
The flow signal was digitized and analyzed using MacLab
software. In each animal, RBF was determined during the
intravenous injection of 1, 10, and 100 ng of ANG II. After
each injection a waiting period of 10 min was allowed in
which RBF and blood pressure returned to baseline.
Perfused afferent arterioles. To determine the effect of
A1AR deficiency on ANG II-induced constriction at the arte-
riolar level, afferent arterioles from A1AR/ and/mice
were isolated and microperfused. Mice (18–26 g) of either sex
were used in the study. The method of isolation and perfusion
was a modification of that used by Weihprecht et al. (18) and
Jensen et al. (9). Afferent arterioles were microdissected at
4°C from slices of mouse kidneys. The dissection was per-
formed in DMEM/Nutrient F12 (DMEM/F12) with 0.5% BSA
under a stereomicroscope. The specimen was transferred to a
thermoregulated chamber, containing oxygenated DMEM/
F12  0.1% BSA, mounted on an inverted microscope (Olym-
pus IMT-2), and perfused with concentric glass pipettes
mounted in a moveable track system. The arteriole was
aspirated into a holding pipette (tip diameter 20 m) and
cannulated with a perfusion pipette (tip diameter 5–6 m).
Once the arteriole was cannulated, the driving pressure was
increased until the vessel opened, and perfusion was estab-
lished. Perfusion was performed close to the minimum open-
ing pressure because it was our impression that the perfused
arterioles from the mouse are rather sensitive to pressure-
induced damage. The perfusate consisting of physiological
salt solution (PSS)  1% BSA was driven from a reservoir
pressurized to 60–110 mmHg. The temperature was in-
creased to 37°C, and the vessel was allowed to recover for 25
min. In each experiment a test stimulus of high potassium
(100 mmol/l K) or a gentle increase in pressure was applied
initially to ensure viability of the vessel. Sequences of inter-
est were recorded with a digital camera (CoolSNAP-Pro,
Media Cybernetics). Images were transferred to a computer,
and intraluminal vessel diameters were assessed using im-
aging software (Image Pro-plus, Media Cybernetics). PSS
had the following composition (mmol/l): 115 NaCl, 25
NaHCO3, 2.5 K2HPO4, 1.3 CaCl2, 1.2 MgSO4, 10 HEPES,
and 5.5 glucose. High-potassium solution contained (mmol/l)
25 NaHCO3, 20 NaCl, 95 KCl, 1.2 MgSO4, 2.5 K2HPO4, 1.3
CaCl2, 10 HEPES, and 5.5 glucose. All solutions were equil-
ibrated with 5% CO2 in O2 for 30 min before use, BSA was
added, and pH was adjusted to 7.35. To study the vasocon-
strictor response to ANG II in arterioles from A1AR wild-type
and knockout mice, ANG II was added to the bath for 3 min
at increasing concentrations (1012, 1011, 1010, 109, and
108 mol/l) using a step-up protocol. Furthermore, in a small
series of experiments in afferent arterioles from A1AR /
mice, we tested the effect of the A1AR-selective antagonist
8-cyclopentyl-1,3-dipropylxanthine (DPCPX) (105 mol/l) on
the vascular response to ANG II (1010 mol/l).
Quantitative real-time PCR. The expression of ANG II
receptors (AT1) in the kidney cortex of 5 A1AR / and 5
A1AR / mice was investigated using real-time PCR anal-
ysis. In addition, we determined the expression levels of
A2aAR and A2bAR in A1AR / compared with A1AR /
mice. RNA was isolated using Trizol-reagent and reverse
transcribed using Superscript (Invitrogen) and oligo(dT)
(Pharmacia). Quantitative PCR analysis was performed us-
ing an ABI prism 7900 HT Sequence Detection System (Ap-
plied Biosystems). SyBR Green, a double-stranded DNA
binding dye, was used for the fluorescent detection of DNA
generated during the PCR. The PCR reaction was performed
in a total volume of 20 l with 0.4 pmol/l of each primer, and
2 SyBR Green PCR master mix (Applied Biosystems); 1 l
cDNA corresponding to 100 ng of total RNA was used as
template. Negative controls included water instead of cDNA
in the PCR reaction and addition of RNA instead of cDNA.
Published sequences for mouse AT1a (S37484), A2aAR
(Y13346), and A2bAR (NM_007413) were used to design
primers for PCR amplification (13). The AT1a primers might
also amplify the AT1b isoform but not the AT2 receptor.
Primer sequences were AT1 sense 5	-CCA GAT CAA GTG
ATT TTG AAC AGT G-3	 and antisense 5	-GCT GTA GAG
AGT AGG GAT CAT GAC AA-3	; A2aAR sense 5	-TCC TGG
TCC TCA CGC AGA GT-3	 and antisense 5	-GGG TCA GGC
CGA TGG C-3	; A2bAR sense 5	-TGG CTG TCG ACC GAT
ATC TG-3	 and antisense 5	-GTC AAT CCA ATG CCA AAG
GC-3	; 
-actin sense 5	-GCT CTG GCT CCT AGC ACC AT-3	
and antisense 5	-GCC ACC GAT CCA CAC AGA GT-3	.
Statistics. Data are expressed as means  SE. Statistical
analysis was performed using the t-test of paired and non-
paired data. Arteriolar diameters were compared by two-way
ANOVA followed by Bonferroni test. Student’s t-test on
paired data in the individual arterioles was performed when
comparing EC50 values. P  0.05 was considered significant.
RESULTS
GFR experiments. The response of GFR to an intra-
venous infusion of ANG II at 10 ng min1 100 g body
wt1 was tested in six female A1AR/ and six female
A1AR / mice. Mean arterial blood pressure in-
creased from 99.3  5.5 to 111.5  7.4 mmHg in /
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mice (P  0.011) and from 107.2  2.9 to 119.8  4.7
mmHg in A1AR/ animals (P 0.02). The difference
in blood pressure between genotypes at baseline was
not statistically significant (P  0.19). The relative
increase in mean arterial blood pressure was similar
between the genotypes (12.2  3.4% in / and 12.6 
4.1% in / mice). Measurements of GFR in six suc-
cessive clearance periods in A1AR / and / mice
are shown in Fig. 1. While GFR values were not differ-
ent between genotypes in any of the control collections,
the fall in GFR in the ANG II infusion period was more
pronounced in the A1AR / mice, reaching signifi-
cance in the second (P  0.045) and third collection
period (P  0.016). Mean GFR for the entire 30-min
control period averaged 450.5  60 and 475.2  62.5
l/min in wild-type and knockout mice, respectively
(P  0.78). During the ANG II infusion, GFR averaged
242  32.5 l/min in wild-type and 371  41.7 l/min
in A1AR knockout mice (P  0.03; Fig. 2). Mean urine
flow rate of wild-type mice was 1.9  0.45 l/min in
control and 3.03  1.35 l/min during angiotensin
infusion (P  0.22). In A1AR / animals, urine flow
rate was 3.7  1.2 l/min in control and 6.6  1.6
l/min during angiotensin infusion (P  0.1). Differ-
ences of urine flow rates in control and ANG II infusion
periods were not significant between genotypes (con-
trol P  0.1, ANG II P  0.08).
RBF studies. Measurements of RBF were performed
in eight wild-type and nine A1AR knockout mice. In
response to intravenous bolus injections of 1, 10, and
100 ng ANG II, RBF of the left kidney fell in the
wild-type mice from 930  12 to 790  9 l/min, from
940 15 to 490 9 l/min, and from 960 18 to 220
7 l/min. In the A1AR knockout mice, the same injec-
tions caused RBF to fall from 1,030  14 to 940  10
l/min, from 1,070  15 to 640  13 l/min, and from
1,080  20 to 400  14 l/min. All changes in both
wild-type and A1AR knockout mice were significant at
P  0.01.
While levels of RBF were not significantly different
before the ANG II injections, RBF was higher during
the ANG II administration in knockout compared with
wild-type mice (P  0.019 at 1 ng, P  0.018 at 10 ng,
and P  0.008 at 100 ng ANG II).
Arterial blood pressure levels were not significantly
different between A1AR / and A1AR / mice even
though they tended to be lower in the latter group
(103 3.5 and 97 2.9 mmHg, respectively; P 0.17).
Furthermore, blood pressure changes in response to
ANG II at 1, 10, and 100 ng were nearly identical,
increasing by 3.3 0.2, 17.3 0.4, and 47.3 1 mmHg
in wild-type and by 3.3  0.15, 18.4  0.4, and 45.5 
0.8 mmHg in the A1AR knockout mice. Because blood
pressures tended to be lower and RBF higher in the
A1AR knockout animals, renal vascular resistance un-
der control conditions was lower in A1AR knockout
than wild-type mice (112.3  1.7 vs. 96.3  1.5 mmHg
min/ml; P  0.05). Increases in renal vascular resis-
tance caused by the injection of 1, 10, and 100 ng of
ANG II are shown in Fig. 3. It can be seen that renal
vascular resistance increased significantly less in the
knockout mice during all three levels of angiotensin
injection (paired t-test).
Studies in perfused afferent arterioles. The vasocon-
strictor response to ANG II was studied in perfused
afferent arterioles from A1AR / and / mice.
Basal diameters averaged 10.1  0.4 m in A1AR
wild-type mice (n  6) and 9.0  0.5 m in knockout
mice (n  7). Administration of 1012 and 1011 mol/l
ANG II had no measurable effect on the inner arterio-
Fig. 2. Average GFR during control and angiotensin infusion periods
of A1AR / and A1AR / mice. Significance levels are given for
comparisons between periods (inside columns) and between geno-
types (above columns).
Fig. 1. Glomerular filtration rate (GFR) of wild-type and A1 adeno-
sine receptor (A1AR) knockout mice in 3 consecutive 10-min periods
during control and during intravenous infusion of ANG II at 1.5
ng/min. Values are means of 6 experiments  SE. *Significance
between A1AR / and / for a given time period (P  0.05).
R46 ANGIOTENSIN IN A1AR KNOCKOUT MICE
AJP-Regul Integr Comp Physiol • VOL 285 • JULY 2003 • www.ajpregu.org






lar diameter in either wild-type or knockout mice. The
addition of 1010 mol/l ANG II to afferent arterioles
from wild-type mice induced a significant vasoconstric-
tion (P  0.05, ANOVA), whereas in knockout mice no
significant vasoconstrictor effect was seen at this ANG
II concentration. However, increasing the ANG II con-
centration to 109 mol/l was associated with significant
constriction in both wild-type and knockout animals
(Fig. 4A). The ANG II concentration causing half-max-
imal vasoconstriction was 1.5  0.4  1010 mol/l in
wild-type mice and 7.3  1.2  1010 mol/l in A1AR
knockout mice (P  0.05, t-test, Fig. 4B). Figure 4C
shows representative examples of perfused afferent
arterioles from wild-type and knockout mice under
control conditions and during exposure to ANG II at
1010 mol/l.
In three A1AR / mice, the addition of DPCPX to
the bath reduced the vasoconstrictor effect of a sub-
maximal dose of ANG II. ANG II (1010 mol/l) reduced
the diameter of the afferent arterioles by 4.0  0.6 m
before DPCPX and by 1.5  1.2 m after DPCPX
administration.
Expression of AT1 and A2AR receptors. To test if the
decreased sensitivity to ANG II in A1AR / mice was
due to a downregulation of AT1 receptors, we deter-
mined the expression of ANG II receptor mRNA in
kidneys of A1AR / and / mice. The expression
levels of AT1 mRNA normalized to 
-actin were found
to be not significantly different in A1AR / (1.0 
0.2) compared with A1AR / mice (1.1  0.3). To test
whether an increase in A2AR expression in the A1AR
/ mice may cause attenuation of the ANG II-in-
duced constriction, we determined the mRNA expres-
sion levels of the A2aAR and A2bAR genes. A2aAR
mRNA levels ranged from 1.1  0.2 in A1AR / to
1.0  0.4 in / mice, and A2bAR ranged from 1.2 
0.3 in / to 0.8  0.2 in / mice (n  4 in each
group). Even though the level of A2bAR tended to be
lower in the / mice, the differences were not signif-
icant.
DISCUSSION
The present experiments show that the renovascular
constrictor response to ANG II is significantly reduced
in mice with a genetic deficiency in the expression of
A1AR. Attenuated constrictor responses at the level of
Fig. 4. A: dose-response relation between bath ANG II concentration
and inner luminal diameter of perfused afferent arterioles of A1AR
/ (closed symbols) and A1AR / mice (open symbols). Curves
represent sigmoidal regression lines calculated by GraphPad Prism
software. B: angiotensin concentrations causing half-maximum-di-
ameter reductions (EC50) of afferent arterioles from wild-type (A1AR
/) and knockout mice (A1AR /). Values are means  SE. C:
images of perfused afferent arterioles from A1AR / and A1AR
/mice during control and during the presence of 1010 mol/l ANG
II in the bath. *P  0.05
Fig. 3. Increases in renal vascular resistance in response to bolus
injections of 1, 10, and 100 ng of ANG II in A1AR/ and A1AR/
mice. Values are means  SE.
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the entire kidney were seen both with subpressor and
with pressor doses of ANG II. Our observation that the
fall in GFR caused by ANG II was also attenuated in
A1AR knockout mice suggests that the reduction in
ANG II constrictor potency is an expression of a re-
duced responsiveness in the preglomerular vascula-
ture. The expression of A1AR in preglomerular mi-
crovessels and glomeruli supports the notion that the
interaction between ANG II and adenosine suggested
by the blood flow and GFR studies takes place for the
most part in afferent arterioles and to a lesser extent
perhaps in larger renal vessels (8, 16). Afferent arte-
rioles as the site of interaction between angiotensin
and adenosine are directly supported by the right shift
in the dose-response relationship observed in isolated
perfused afferent arterioles.
In view of the observation that the expression levels
of ANG II receptor mRNA were comparable between
A1AR / and / mice, we consider it unlikely that
differences in AT1 receptor density are responsible for
the reduced angiotensin sensitivity in the A1AR knock-
out mice. Furthermore, the unchanged expression lev-
els of both A2a and A2b adenosine receptors between
A1AR / and A1AR / mice do not support the
possibility that an increase in A2AR abundance and
activation may be responsible for the attenuation of the
ANG II-induced response in the A1AR / animals.
While there could be a number of other reasons for the
lower renal vascular responsiveness to ANG II in
A1AR knockout mice, it would seem most likely that it
is an expression of the previously noted relation be-
tween angiotensin-induced constriction and A1AR ac-
tivation. Studies from our laboratory have shown that
the constrictor effect of ANG II in isolated rabbit affer-
ent arterioles was blocked by 50% when the A1AR
inhibitor DPCPX was present in the bath (17), a find-
ing that was reproduced in the present studies in
mouse afferent arterioles. In confirmation of an earlier
observation, a recent study in dogs showed that the
reduction in RBF caused by ANG II was augmented by
intrarenal infusion of adenosine and attenuated by the
A1AR antagonist KW-3902 (1, 6). The present study is
the first to demonstrate that the vasoconstricting ef-
fects of acute changes in plasma ANG II levels are
attenuated in animals with a life-long absence of
A1AR. Thus the fundamental mechanism by which
adenosine affects angiotensin actions in renal blood
vessels does not seem to adapt to chronic A1AR defi-
ciency.
It seems reasonable to predict that the effect of
adenosine blockade on the ANG II-induced vasocon-
striction may depend on the level of expression of
A1AR in a given vascular bed. Thus in a vascular bed
with low levels of A1AR expression, the effect of A1AR
inhibition on angiotensin responses should be low. We
believe that this notion may be the explanation for
some of the apparently discrepant results that can be
found in the literature. For example, blockade of A1AR
did not measurably affect ANG II-induced vasocon-
striction in afferent arterioles of juxtamedullary
nephrons (3). Functional evidence mainly based on the
vasoconstrictor efficacy of adenosine would indicate
that the nucleoside causes no more than a 10% reduc-
tion in afferent arteriolar diameter and that even when
A2AR receptors are blocked, the maximum vasocon-
striction is only 15% (3, 10). In contrast, A1AR activa-
tion has previously been observed to cause a 45–50%
diameter reduction in more superficial afferent arte-
rioles of the rabbit and in the hydronephrotic kidney
preparation (7, 19). We believe that this dataset is most
likely a reflection of a markedly lower abundance of
A1AR in deep nephrons. Thus any interaction between
AT1 and A1AR activation would be expected to be less
obvious in juxtamedullary afferent arterioles, an ex-
pectation directly supported by the observation that
converting enzyme blockade reduced the vasoconstric-
tion caused by N6-cyclohexyladenosine in superficial
arterioles but enhanced it in juxtamedullary arterioles
(5). A second important variable may be the rate of
production of adenosine and its appearance in and
around the A1AR expressing vessels. In the hydrone-
phrotic kidney preparation, the selective A1AR antag-
onist DPCPX did not alter the vasoconstrictor effect of
ANG II (4). If one assumes that the source of adenosine
or its precursor ATP is predominantly the renal epi-
thelial cells, one would not expect A1AR to be highly
activated in a preparation that is devoid of epithelial
structures.
The mechanisms responsible for the effect of A1AR
activation on ANG II responsiveness have not been
addressed in this study. However, there is substantial
evidence for a synergistic interaction between Gq- and
Gi-coupled receptors using a variety of different ago-
nists in a number of different tissues. Overall, these
studies show that activation of Gi-coupled receptors
such as A1AR often synergistically enhances the accu-
mulation of inositol trisphosphate and subsequent in-
creases in cytosolic calcium caused by activation of
Gq-coupled receptors. The underlying reason appears
to be an enhanced activation of phospholipase C, re-
sulting from simultaneous exposure to Gq and to the
G
 dimers dissociated from Gi (21). There is also
evidence that this synergy is especially effective in cells
with a high level of A1AR expression, and this may
explain why afferent arterioles are a site where the
angiotensin-adenosine interactions are detectable
most clearly (2). Further studies are needed to test the
validity of this concept in the renal vasculature.
ANG II has been found in the present experiments to
constrict isolated afferent arterioles from wild-type
mice with an EC50 of1010 M and to cause maximum
constriction consisting of essentially complete vessel
closure at 109 M. In previous studies in perfused
afferent arterioles from rabbits and rats, EC50 values
for ANG II vasoconstriction of 109 M and maximum
effects at 107 M have been reported, suggesting that
mouse arterioles may be somewhat more sensitive to
ANG II (18, 20). This conclusion is slightly at variance
with a study in which vasoconstriction of isolated per-
fused afferent arterioles from the mouse required
higher threshold concentrations of ANG II and in
which the maximum effect consisted of an about 30–
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40% reduction in diameter (12). Effects comparable to
those seen in our study were only observed when ves-
sels were treated with the NOS blocker L-NAME, sug-
gesting that the effect of ANG II was counteracted by
the release of nitric oxide. Whether differences in en-
dothelial function are responsible for the enhanced
response to ANG II in our studies remains to be deter-
mined. Compared with vessels isolated from wild-type
mice, arterioles originating from A1AR knockout mice
had a significantly lower response to ANG II in the
threshold concentration range around 1010 M, result-
ing in a significant right shift of the dose-response
relationship and a significantly higher EC50 concentra-
tion. This observation indicates that vessels from wild-
type mice generate adenosine that via activation of
A1AR enhances the effect of ANG II.
In conclusion, the reduction in GFR and the increase
in renal vascular resistance caused by acute ANG II
administration is significantly reduced in A1AR knock-
out mice. Furthermore, the relationship between bath
ANG II and vasoconstriction of isolated perfused affer-
ent arterioles is shifted to the right in vessels from
A1AR knockout compared with vessels from wild-type
mice. Thus chronic absence of A1AR diminishes the
effectiveness of ANG II to constrict renal resistance
vessels.
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